Response to "An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis" by White et al

Comment

K F Phillips. J Pharmacokinet Biopharm. 1992 Aug.

. 1992 Aug;20(4):389-95.

doi: 10.1007/BF01062464.

No abstract available

Comment on

An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.
White DB, Walawander CA, Tung Y, Grasela TH. White DB, et al. J Pharmacokinet Biopharm. 1991 Feb;19(1):87-112. doi: 10.1007/BF01062194. J Pharmacokinet Biopharm. 1991. PMID: 2023111

An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.
White DB, Walawander CA, Tung Y, Grasela TH. White DB, et al. J Pharmacokinet Biopharm. 1991 Feb;19(1):87-112. doi: 10.1007/BF01062194. J Pharmacokinet Biopharm. 1991. PMID: 2023111
A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
Bauer RJ, Guzy S, Ng C. Bauer RJ, et al. AAPS J. 2007 Mar 2;9(1):E60-83. doi: 10.1208/aapsj0901007. AAPS J. 2007. PMID: 17408237 Free PMC article. Review.
Errors in time in pharmacokinetic studies.
Jia X, Nedelman JR. Jia X, et al. J Biopharm Stat. 1996 Jul;6(3):303-18. doi: 10.1080/10543409608835145. J Biopharm Stat. 1996. PMID: 8854234
Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM.
Jonsson EN, Karlsson MO. Jonsson EN, et al. Comput Methods Programs Biomed. 1999 Jan;58(1):51-64. doi: 10.1016/s0169-2607(98)00067-4. Comput Methods Programs Biomed. 1999. PMID: 10195646
A Critique of Computer Simulation Software's Used in Pharmacokinetics and Pharmacodynamics Analysis.
Dave V, Yadav RB, Yadav S, Sharma S, Sahu RK, Ajayi AF. Dave V, et al. Curr Clin Pharmacol. 2018;13(4):216-235. doi: 10.2174/1574884713666181025144845. Curr Clin Pharmacol. 2018. PMID: 30360723 Review.